Abcuro, Inc. raised $200 million in a Series C financing led by New Enterprise Associates to advance its first-in-class medicine targeting inclusion body myositis.
Amount Raised
$200 Million
Round Type
Series C
NewtonvilleBiotechnologyHealth CareTherapeuticsInvestors
Description
Abcuro, Inc. announced the closing of a $200 million Series C financing to support the registrational Phase 2/3 MUSCLE clinical trial for ulviprubart, a novel monoclonal antibody. The funding will also facilitate the commercial launch preparation assuming positive trial results.
Quick answer
Abcuro raised $200 Million in a Series C round, dated February 12, 2025. Investors: Eurofarma Ventures, Samsara Biocapital, Mass General Brigham Ventures, Bain Capital Life Sciences, RA Capital Management, Abrdn Inc., Blackrock and Soleus Capital. Abcuro is based in Newtonville, Massachusetts, United States.
- How much did Abcuro raise?
- Abcuro raised $200 Million in a Series C round on February 12, 2025.
- Who invested in Abcuro?
- Eurofarma Ventures, Samsara Biocapital, Mass General Brigham Ventures, Bain Capital Life Sciences, RA Capital Management, Abrdn Inc., Blackrock and Soleus Capital are named as investors in this round.
- What does Abcuro do?
- Abcuro is a clinical stage biotechnology company developing treatments for autoimmune and cancer indications modulated by cytotoxic T and NK cells that express the inhibitory immune checkpoint receptor KLRG1 (killer..
- Where is Abcuro based and how big is it?
- Abcuro is based in Newtonville, Massachusetts, United States.
- Who are the decision-makers at Abcuro?
- Fundz holds 2 contacts at Abcuro, including the Executive Officer, Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Abcuro that raised within 45 days of this round, from Fundz verified event records.
- NewcelX raised $2M (Seed) on March 28, 2025.
- Epicrispr Biotechnologies raised $68M (Series B) on March 27, 2025.
- Surrozen raised $76M on March 26, 2025.
- Tribune Therapeutics raised $40M (Seed) on March 26, 2025.
- Hillstar Bio raised $67M (Series A) on March 25, 2025.
- Tempero Bio raised $70M (Series B) on March 24, 2025.
Who to call at Abcuro, and when
A new round usually means Abcuro is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Abcuro raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Abcuro, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Abcuro. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Abcuro raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Abcuro raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.